CR2TI UMR 1064 Nantes’ Post

View organization page for CR2TI UMR 1064 Nantes, graphic

690 followers

Questions about the BEST-Fluid Trial? Christophe Masset , Lucile Figueres and colleagues at ITUN and CR2TI UMR 1064 Nantes are in correspondence in The Lancet with the authors of the clinical study and the use of balanced crystalloid solutions to prevent kidney damage (DGF) after transplantation. Although the results are promising, more research is needed to confirm their efficacy, especially in light of new organ preservation techniques such as machine perfusion. To further reduce DGF, several factors have been identified: minimizing organ damage during surgery, using advanced preservation methods, optimizing anti-rejection medications, and potentially using new treatments for both donors and organs. CHU de Nantes Nantes Université INSERM SFNDT - Société Francophone de Néphrologie, Dialyse et Transplantation ESOT - European Society for Organ Transplantation https://lnkd.in/exfsaBae

  • No alternative text description for this image
jerome guicheux

Director, INSERM UMR 1229-RMeS, regenerative medicine and skeleton research centre.

6mo

Congrats Lucile Figueres and the team 👍

To view or add a comment, sign in

Explore topics